← Back to Clinical Trials
Recruiting NCT05470439

NCT05470439 My Interprofessional Care Team for Adherence and Research Engagement Disparities

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05470439
Status Recruiting
Phase
Sponsor University of Arizona
Condition Medication Adherence
Study Type INTERVENTIONAL
Enrollment 217 participants
Start Date 2023-08-30
Primary Completion 2026-03-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
My Interprofessional Care team for Adherence and Research Engagement (MI-CARE)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 217 participants in total. It began in 2023-08-30 with a primary completion date of 2026-03-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

MI-CARE is an innovative coordinated care team intervention to improve medication adherence and blood pressure derived from research findings that build on existing clinical practice. Designed with an eye toward sustainability, MI-CARE incorporates billable pharmacist and CHW services for patients with low medication adherence and high burdens of chronic illness and preventable consequences. MI-CARE offers interprofessional team care with comprehensive expertise and complementary skill sets that mitigate the silo effect of specialized medicine to deliver primary care to diverse, high-risk populations experiencing disparities in hypertension.

Eligibility Criteria

Inclusion Criteria: 1. age ≥ 18 years; 2. self-report cultural identity as African-American, or Latino; 3. speak English, or Spanish; 4. have medication-treated hypertension; 5. use ≥5 chronic medications; 6. have hypertension medication adherence \<85%; and 7. able to provide informed consent. Exclusion Criteria: 1. if project staff conclude that a candidate participant is unable to comprehend the informed consent process (because he/she offers an inappropriate response to consent questions); or 2. if the candidate is hostile or unwilling to follow project protocols.

Contact & Investigator

Central Contact

Vrinda Prakash, MPH

✉ vprakash@caringhealth.org

📞 413-739-1100

Principal Investigator

Jeannie K Lee, PharmD

PRINCIPAL INVESTIGATOR

University of Arizona College of Pharmacy

Frequently Asked Questions

Who can join the NCT05470439 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Medication Adherence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05470439 currently recruiting?

Yes, NCT05470439 is actively recruiting participants. Contact the research team at vprakash@caringhealth.org for enrollment information.

Where is the NCT05470439 trial being conducted?

This trial is being conducted at Springfield, United States.

Who is sponsoring the NCT05470439 clinical trial?

NCT05470439 is sponsored by University of Arizona. The principal investigator is Jeannie K Lee, PharmD at University of Arizona College of Pharmacy. The trial plans to enroll 217 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology